Evaluating Health-Related Quality of Life in Interstitial Lung Disease Patients With and Without Lung Transplantation Using the GR-Scale

• by Sina Stoltefuß, Gabriela Leuschner, Tobias Veit, Jeremias Götschke, Katrin Milger, Teresa Kauke, Alexandra Lenoir, Nikolaus Kneidinger, Jürgen Behr

• January 10, 2026

Cataract Risk Elevated in Pneumoconiosis

Researchers assess whether occupational lung disease is linked to long-term eye outcomes.

• by Kathryn Wighton

• February 3, 2026

• 3 min

Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis

• by Cheng Jiang, Sihao Cui, Shixuan Hou, Min Chen, Qiuyan Huang, Xiangyu Zhang, Sijia Li, Deqin Yang, Mengshu Cao

• February 10, 2026

Temple Lung Center: Advancing Research in ILD

Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.

• by

• April 28, 2025

• 2 min